Melatonin regulates matrix metalloproteinases after traumatic experimental spinal cord injury
- 12 August 2008
- journal article
- Published by Wiley in Journal of Pineal Research
- Vol. 45 (2) , 149-156
Abstract
Abstract: The matrix metalloproteinases (MMPs) are important enzymes that regulate developmental processes, maintain normal physiology in adulthood and have reparative roles at specific stages after an insult to the nervous system. MMPs, particularly MMP‐9/gelatinase B, promote early inflammation and barrier disruption after spinal cord injury (SCI). Recently, we have reported that the pineal secretory product melatonin exerts important anti‐inflammatory effects in an experimental model of SCI induced by the application of vascular clips (force of 24 g) to the dura after a four‐level T5–T8 laminectomy. However, no reports are available on the relationship between the activity of MMPs and melatonin’s anti‐inflammatory effects. The aim of the present study was to evaluate whether the protective effect of melatonin observed in SCI is related to the regulation of MMP‐9 and MMP‐2 in mice. Biochemical and zymographic methods were used to analyze MMP‐9 and ‐2 expression and activities in spinal cord tissue from SCI‐treated mice at 24 hr after the trauma. Our studies reveal that melatonin reduced SCI and lipid peroxidation in spinal cord at 24 hr after SCI. Melatonin also diminished proMMP‐9 and ‐2 activities that were induced in the spinal cord tissues at 24 hr after SCI. The reduced activities of MMP‐9 and ‐2 were associated with depressed expression of TNF‐α. We propose that melatonin’s ability to reduce SCI in mice is also related to a reduction in MMP‐9 and MMP‐2 activity and expression.Keywords
This publication has 73 references indexed in Scilit:
- Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injuryBMC Neurology, 2007
- Persistent Macrophage/Microglial Activation and Myelin Disruption after Experimental Autoimmune Encephalomyelitis in Tissue Inhibitor of Metalloproteinase-1-Deficient MiceThe American Journal of Pathology, 2006
- Matrix Metalloproteinase-2 Facilitates Wound Healing Events That Promote Functional Recovery after Spinal Cord InjuryThe Journal of Neuroscience, 2006
- Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood–brain barrier permeability after transient focal cerebral ischemia in miceJournal of Pineal Research, 2006
- Immunomodulatory Effects of Etanercept in an Experimental Model of Spinal Cord InjuryThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Modulation of nitric oxide homeostasis in a mouse model of spinal cord injuryJournal of Neurosurgery: Spine, 2006
- Melatonin is a scavenger of peroxynitriteLife Sciences, 1997
- Update on the Pathophysiology and Pathology of Acute Spinal Cord InjuryBrain Pathology, 1995
- Pathophysiology of spinal cord traumaAnnals of Emergency Medicine, 1993
- Spinal cord injury in rats: inability of nimodipine or anti-neutrophil serum to improve spinal cord blood flow or neurologic statusActa Neurologica Scandinavica, 1989